"टेस्टोस्टेरॉन": अवतरणों में अंतर

नया पृष्ठ: {{Drugbox| Watchedfields = changed | verifiedrevid = 265997766 | IUPAC_name = (8''R'',9''S'',10''R'',13''S'',14''S'',17''S'')- 17-hydroxy-10,13-dimethyl- 1,2,6,7,8,9,11,12...
 
No edit summary
पंक्ति 17:
| C=19 | H=28 | O=2
| molecular_weight = 288.42
| bioavailability= lowनिम्न (due to extensive [[First pass effect|first pass metabolism]])
| metabolism = [[Liverयकृत]], [[Testisअंडकोष]] andएवं [[Prostateप्रोस्टेट]]
| elimination_half-life= 2-4 hoursघंटे
| excretion = [[Urineमूत्र]] (90९०%), fecesमल (6%)
| pregnancy_category = X ([[United States|USA]]), [[Teratogen]]ic effects
| legal_status = Schedule III ([[Controlled Substances Act|USA]])<br />Schedule IV ([[Controlled Drugs and Substances Act|Canada]])
| routes_of_administration=Intramuscular injection, transdermal (cream, gel, or patch), sub-'Q' pellet
| melting_point =155
| melting_high =156